We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EDBL:NASDAQEdible Garden AG Incorporated Analysis

Data as of 2026-06-14 - not real-time

$0.26

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Edible Garden AG Incorporated (EDBL) trades at $0.2574, well below its 20‑day SMA of 0.258 and far under the 50‑day SMA of 0.512, indicating a bearish price bias. The RSI 14 sits at 35.6, suggesting the stock is approaching oversold conditions, while the MACD line (-0.092) is just above its signal (-0.123), producing a modest bullish histogram (+0.031). Volatility is extreme at 148% over the past 30 days and beta exceeds 2.1, reflecting high market sensitivity. Fundamentals are weak: gross margin is negative (-8.8%), operating margin plunges to -199.9%, and the company posted a trailing EPS of -$98.15 with a max drawdown of -99.3%. Despite these challenges, revenue grew 22.9% year‑over‑year, driven by an expanded distribution agreement with Target and higher‑margin product lines. The balance sheet shows modest cash ($1.95 M) versus debt ($3.39 M), and no dividend is paid. Overall, the stock presents a classic high‑risk, low‑price play where technical signals hint at a possible short‑term bounce, but structural financial weakness and extreme volatility dominate the outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price just below 20‑day SMA with modest bullish MACD histogram
  • RSI approaching oversold territory
  • Decreasing volume trend reducing immediate liquidity

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • 22.9% revenue growth and new Target distribution partnership
  • Persistently negative margins and earnings
  • High beta and 30‑day volatility indicating market‑wide risk

Long Term

> 3 years
Cautious
Model confidence: 3/10

Key Factors

  • Sustained operating losses and negative cash flow
  • Extreme max drawdown and lack of profitability trajectory
  • Elevated liquidity risk and volatile price action

Key Metrics & Analysis

Financial Health

Revenue Growth22.90%
Profit Margin-131.59%
P/E Ratio-0.0
ROE-328.84%
ROA-93.95%
Debt/Equity38.39
P/B Ratio-0.1

Technical Analysis

TrendBearish
RSI35.6
Support$0.18
Resistance$0.56
MA 20$0.26
MA 50$0.51
MA 200$8.08
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.17
Volatility148.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.